CONMED Corporation has appointed John Gallagher as Chief Financial Officer, adding a seasoned healthcare and public-company finance executive to its leadership team. In this role, he will oversee the company's financial strategy, planning, reporting, and capital allocation activities while supporting CONMED's continued growth in the medical technology sector. Gallagher joins the organization at a time when healthcare companies are balancing innovation investments with operational and financial discipline.
Gallagher brings extensive experience in corporate finance, investor relations, financial planning, and strategic execution within the healthcare industry. Throughout his career, he has held senior financial leadership positions at publicly traded healthcare and medical technology organizations, helping guide business growth, operational performance, and shareholder value creation. His background includes leading finance functions through periods of expansion, transformation, and market change.
Why this matters: Financial leadership is increasingly important for medical technology companies navigating evolving healthcare demands, regulatory requirements, and global market opportunities. By appointing an experienced healthcare finance executive, CONMED is reinforcing its focus on disciplined growth, operational efficiency, and long-term value creation while continuing to invest in innovation and market expansion.
Join the conversation on LinkedInConnect with John Gallagher on LinkedIn
